Intervacc AB (FRA:2E9) ROCE %: -33.83% (As of Mar. 2026)


FRA:2E9 Intervacc AB FRA:2E9
63 GF Score
Price €0.07
GF Value €0.06
! 5 Warning Signs
View Full Analysis

What is Intervacc AB ROCE %?

Intervacc AB FRA:2E9 63 ROCE % is -33.83% as of Mar. 2026. GuruFocus rates FRA:2E9 with a GF Score™ of 63/100 and a GF Value™ of €0.06. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Intervacc AB's annualized ROCE % for the quarter that ended in Mar. 2026 was -33.83%.

Intervacc AB  (FRA:2E9) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Intervacc AB ROCE % Related Terms

Intervacc AB ROCE % Historical Data

* Premium members only.

The historical data trend for Intervacc AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intervacc AB ROCE % Chart

Intervacc AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.02 -22.06 -37.07 -37.02 -37.70

Intervacc AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.78 -22.24 -18.86 -49.99 -33.83
FRA:2E9
63GF Score
Intervacc AB FRA:2E9
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intervacc AB ROCE % Calculation

Intervacc AB's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-7.425/( ( (16.285 - 2.163) + (27.056 - 1.788) )/ 2 )
=-7.425/( (14.122+25.268)/ 2 )
=-7.425/19.695
=-37.70 %

Intervacc AB's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-8.256/( ( (27.056 - 1.788) + (25.831 - 2.292) )/ 2 )
=-8.256/( ( 25.268 + 23.539 )/ 2 )
=-8.256/24.4035
=-33.83 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -33.83% mean?
Intervacc AB (FRA:2E9) has a ROCE % of -33.83% as of Mar. 2026.
Is Intervacc AB's ROCE % too high?
Intervacc AB's current ROCE % is -33.83%. Overall, Intervacc AB has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Intervacc AB's ROCE % compare to VRTX and REGN?
Intervacc AB's ROCE % of -33.83% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Intervacc AB's current ROCE % is -33.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intervacc AB stock overvalued right now?
Intervacc AB (FRA:2E9) has a current ROCE % of -33.83%. The stock's GF Value™ is €0.06, compared to a current price of €0.07 — trading 12.2% above its estimated fair value. The current ROCE % is -33.83%. Intervacc AB's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Intervacc AB (FRA:2E9), the current ROCE % is -33.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intervacc AB (FRA:2E9) Overvalued in 2026?

Based on GuruFocus' analysis, Intervacc AB stock appears to be overvalued. The current stock price of €0.07 is trading 12.2% above its estimated GF Value™ of €0.06.

Key valuation signals for FRA:2E9:

  • ROCE %: -33.83%
  • GF Value™: €0.06 vs. price of €0.07 (12.2% above fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the FRA:2E9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intervacc AB Business Description

Other Exchanges IVACC:Sweden
Address Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44
Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.
63GF Score

Get the complete analysis for FRA:2E9

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.07
Price
€0.06
GF Value